NCT04042155View on ClinicalTrials.gov

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

RecruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Atrial FibrillationRecurrent Venous Thromboembolism
Interventions
DRUG

dabigatran, rivaroxaban, apixaban or edoxaban

Record of all serious complications associated with any of the drugs and the clinical changes that occurred during prospective follow-up.

Trial Locations (1)

08025

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER